Transdermal Scopolamine Market
1 Study Coverage
1.1 Transdermal Scopolamine Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Scopolamine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablet Type
1.2.3 Syrups Type
1.2.4 Injections Type
1.2.5 Patch Type
1.2.6 Gel Type
1.3 Market by Application
1.3.1 Global Transdermal Scopolamine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Narcotic Analgesia
1.3.3 Cough
1.3.4 Asthma
1.3.5 Motion Sickness
1.3.6 Parkinson's Disease
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transdermal Scopolamine Sales Estimates and Forecasts 2017-2028
2.2 Global Transdermal Scopolamine Revenue Estimates and Forecasts 2017-2028
2.3 Global Transdermal Scopolamine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Transdermal Scopolamine Sales by Region
2.4.1 Global Transdermal Scopolamine Sales by Region (2017-2022)
2.4.2 Global Sales Transdermal Scopolamine by Region (2023-2028)
2.5 Global Transdermal Scopolamine Revenue by Region
2.5.1 Global Transdermal Scopolamine Revenue by Region (2017-2022)
2.5.2 Global Transdermal Scopolamine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Transdermal Scopolamine Sales by Manufacturers
3.1.1 Global Top Transdermal Scopolamine Manufacturers by Sales (2017-2022)
3.1.2 Global Transdermal Scopolamine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Transdermal Scopolamine in 2021
3.2 Global Transdermal Scopolamine Revenue by Manufacturers
3.2.1 Global Transdermal Scopolamine Revenue by Manufacturers (2017-2022)
3.2.2 Global Transdermal Scopolamine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Transdermal Scopolamine Revenue in 2021
3.3 Global Transdermal Scopolamine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Transdermal Scopolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Transdermal Scopolamine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Transdermal Scopolamine Sales by Type
4.1.1 Global Transdermal Scopolamine Historical Sales by Type (2017-2022)
4.1.2 Global Transdermal Scopolamine Forecasted Sales by Type (2023-2028)
4.1.3 Global Transdermal Scopolamine Sales Market Share by Type (2017-2028)
4.2 Global Transdermal Scopolamine Revenue by Type
4.2.1 Global Transdermal Scopolamine Historical Revenue by Type (2017-2022)
4.2.2 Global Transdermal Scopolamine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Transdermal Scopolamine Revenue Market Share by Type (2017-2028)
4.3 Global Transdermal Scopolamine Price by Type
4.3.1 Global Transdermal Scopolamine Price by Type (2017-2022)
4.3.2 Global Transdermal Scopolamine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Transdermal Scopolamine Sales by Application
5.1.1 Global Transdermal Scopolamine Historical Sales by Application (2017-2022)
5.1.2 Global Transdermal Scopolamine Forecasted Sales by Application (2023-2028)
5.1.3 Global Transdermal Scopolamine Sales Market Share by Application (2017-2028)
5.2 Global Transdermal Scopolamine Revenue by Application
5.2.1 Global Transdermal Scopolamine Historical Revenue by Application (2017-2022)
5.2.2 Global Transdermal Scopolamine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Transdermal Scopolamine Revenue Market Share by Application (2017-2028)
5.3 Global Transdermal Scopolamine Price by Application
5.3.1 Global Transdermal Scopolamine Price by Application (2017-2022)
5.3.2 Global Transdermal Scopolamine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Transdermal Scopolamine Market Size by Type
6.1.1 North America Transdermal Scopolamine Sales by Type (2017-2028)
6.1.2 North America Transdermal Scopolamine Revenue by Type (2017-2028)
6.2 North America Transdermal Scopolamine Market Size by Application
6.2.1 North America Transdermal Scopolamine Sales by Application (2017-2028)
6.2.2 North America Transdermal Scopolamine Revenue by Application (2017-2028)
6.3 North America Transdermal Scopolamine Market Size by Country
6.3.1 North America Transdermal Scopolamine Sales by Country (2017-2028)
6.3.2 North America Transdermal Scopolamine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Transdermal Scopolamine Market Size by Type
7.1.1 Europe Transdermal Scopolamine Sales by Type (2017-2028)
7.1.2 Europe Transdermal Scopolamine Revenue by Type (2017-2028)
7.2 Europe Transdermal Scopolamine Market Size by Application
7.2.1 Europe Transdermal Scopolamine Sales by Application (2017-2028)
7.2.2 Europe Transdermal Scopolamine Revenue by Application (2017-2028)
7.3 Europe Transdermal Scopolamine Market Size by Country
7.3.1 Europe Transdermal Scopolamine Sales by Country (2017-2028)
7.3.2 Europe Transdermal Scopolamine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Transdermal Scopolamine Market Size by Type
8.1.1 Asia Pacific Transdermal Scopolamine Sales by Type (2017-2028)
8.1.2 Asia Pacific Transdermal Scopolamine Revenue by Type (2017-2028)
8.2 Asia Pacific Transdermal Scopolamine Market Size by Application
8.2.1 Asia Pacific Transdermal Scopolamine Sales by Application (2017-2028)
8.2.2 Asia Pacific Transdermal Scopolamine Revenue by Application (2017-2028)
8.3 Asia Pacific Transdermal Scopolamine Market Size by Region
8.3.1 Asia Pacific Transdermal Scopolamine Sales by Region (2017-2028)
8.3.2 Asia Pacific Transdermal Scopolamine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Transdermal Scopolamine Market Size by Type
9.1.1 Latin America Transdermal Scopolamine Sales by Type (2017-2028)
9.1.2 Latin America Transdermal Scopolamine Revenue by Type (2017-2028)
9.2 Latin America Transdermal Scopolamine Market Size by Application
9.2.1 Latin America Transdermal Scopolamine Sales by Application (2017-2028)
9.2.2 Latin America Transdermal Scopolamine Revenue by Application (2017-2028)
9.3 Latin America Transdermal Scopolamine Market Size by Country
9.3.1 Latin America Transdermal Scopolamine Sales by Country (2017-2028)
9.3.2 Latin America Transdermal Scopolamine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Transdermal Scopolamine Market Size by Type
10.1.1 Middle East and Africa Transdermal Scopolamine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Transdermal Scopolamine Revenue by Type (2017-2028)
10.2 Middle East and Africa Transdermal Scopolamine Market Size by Application
10.2.1 Middle East and Africa Transdermal Scopolamine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Transdermal Scopolamine Revenue by Application (2017-2028)
10.3 Middle East and Africa Transdermal Scopolamine Market Size by Country
10.3.1 Middle East and Africa Transdermal Scopolamine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Transdermal Scopolamine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Baxter International
11.1.1 Baxter International Corporation Information
11.1.2 Baxter International Overview
11.1.3 Baxter International Transdermal Scopolamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Baxter International Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Baxter International Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Transdermal Scopolamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG Transdermal Scopolamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis AG Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis AG Recent Developments
11.4 Perrigo Company
11.4.1 Perrigo Company Corporation Information
11.4.2 Perrigo Company Overview
11.4.3 Perrigo Company Transdermal Scopolamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Perrigo Company Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Perrigo Company Recent Developments
11.5 Caleb Pharmaceuticals
11.5.1 Caleb Pharmaceuticals Corporation Information
11.5.2 Caleb Pharmaceuticals Overview
11.5.3 Caleb Pharmaceuticals Transdermal Scopolamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Caleb Pharmaceuticals Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Caleb Pharmaceuticals Recent Developments
11.6 Myungmoon Pharma
11.6.1 Myungmoon Pharma Corporation Information
11.6.2 Myungmoon Pharma Overview
11.6.3 Myungmoon Pharma Transdermal Scopolamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Myungmoon Pharma Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Myungmoon Pharma Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Transdermal Scopolamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Pfizer Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 Nichi-Iko
11.8.1 Nichi-Iko Corporation Information
11.8.2 Nichi-Iko Overview
11.8.3 Nichi-Iko Transdermal Scopolamine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Nichi-Iko Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Nichi-Iko Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Transdermal Scopolamine Industry Chain Analysis
12.2 Transdermal Scopolamine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Transdermal Scopolamine Production Mode & Process
12.4 Transdermal Scopolamine Sales and Marketing
12.4.1 Transdermal Scopolamine Sales Channels
12.4.2 Transdermal Scopolamine Distributors
12.5 Transdermal Scopolamine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Transdermal Scopolamine Industry Trends
13.2 Transdermal Scopolamine Market Drivers
13.3 Transdermal Scopolamine Market Challenges
13.4 Transdermal Scopolamine Market Restraints
14 Key Findings in The Global Transdermal Scopolamine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Transdermal Scopolamine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablet Type
Table 3. Major Manufacturers of Syrups Type
Table 4. Major Manufacturers of Injections Type
Table 5. Major Manufacturers of Patch Type
Table 6. Major Manufacturers of Gel Type
Table 7. Global Transdermal Scopolamine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Transdermal Scopolamine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Transdermal Scopolamine Sales by Region (2017-2022) & (K Units)
Table 10. Global Transdermal Scopolamine Sales Market Share by Region (2017-2022)
Table 11. Global Transdermal Scopolamine Sales by Region (2023-2028) & (K Units)
Table 12. Global Transdermal Scopolamine Sales Market Share by Region (2023-2028)
Table 13. Global Transdermal Scopolamine Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Transdermal Scopolamine Revenue Market Share by Region (2017-2022)
Table 15. Global Transdermal Scopolamine Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Transdermal Scopolamine Revenue Market Share by Region (2023-2028)
Table 17. Global Transdermal Scopolamine Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Transdermal Scopolamine Sales Share by Manufacturers (2017-2022)
Table 19. Global Transdermal Scopolamine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Transdermal Scopolamine Revenue Share by Manufacturers (2017-2022)
Table 21. Transdermal Scopolamine Price by Manufacturers (2017-2022) &(USD/Unit)
Table 22. Global Transdermal Scopolamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Transdermal Scopolamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Scopolamine as of 2021)
Table 24. Transdermal Scopolamine Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Transdermal Scopolamine Product Offered
Table 26. Date of Manufacturers Enter into Transdermal Scopolamine Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Transdermal Scopolamine Sales by Type (2017-2022) & (K Units)
Table 29. Global Transdermal Scopolamine Sales by Type (2023-2028) & (K Units)
Table 30. Global Transdermal Scopolamine Sales Share by Type (2017-2022)
Table 31. Global Transdermal Scopolamine Sales Share by Type (2023-2028)
Table 32. Global Transdermal Scopolamine Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Transdermal Scopolamine Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Transdermal Scopolamine Revenue Share by Type (2017-2022)
Table 35. Global Transdermal Scopolamine Revenue Share by Type (2023-2028)
Table 36. Transdermal Scopolamine Price by Type (2017-2022) & (USD/Unit)
Table 37. Global Transdermal Scopolamine Price Forecast by Type (2023-2028) & (USD/Unit)
Table 38. Global Transdermal Scopolamine Sales by Application (2017-2022) & (K Units)
Table 39. Global Transdermal Scopolamine Sales by Application (2023-2028) & (K Units)
Table 40. Global Transdermal Scopolamine Sales Share by Application (2017-2022)
Table 41. Global Transdermal Scopolamine Sales Share by Application (2023-2028)
Table 42. Global Transdermal Scopolamine Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Transdermal Scopolamine Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Transdermal Scopolamine Revenue Share by Application (2017-2022)
Table 45. Global Transdermal Scopolamine Revenue Share by Application (2023-2028)
Table 46. Transdermal Scopolamine Price by Application (2017-2022) & (USD/Unit)
Table 47. Global Transdermal Scopolamine Price Forecast by Application (2023-2028) & (USD/Unit)
Table 48. North America Transdermal Scopolamine Sales by Type (2017-2022) & (K Units)
Table 49. North America Transdermal Scopolamine Sales by Type (2023-2028) & (K Units)
Table 50. North America Transdermal Scopolamine Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Transdermal Scopolamine Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Transdermal Scopolamine Sales by Application (2017-2022) & (K Units)
Table 53. North America Transdermal Scopolamine Sales by Application (2023-2028) & (K Units)
Table 54. North America Transdermal Scopolamine Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Transdermal Scopolamine Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Transdermal Scopolamine Sales by Country (2017-2022) & (K Units)
Table 57. North America Transdermal Scopolamine Sales by Country (2023-2028) & (K Units)
Table 58. North America Transdermal Scopolamine Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Transdermal Scopolamine Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Transdermal Scopolamine Sales by Type (2017-2022) & (K Units)
Table 61. Europe Transdermal Scopolamine Sales by Type (2023-2028) & (K Units)
Table 62. Europe Transdermal Scopolamine Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Transdermal Scopolamine Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Transdermal Scopolamine Sales by Application (2017-2022) & (K Units)
Table 65. Europe Transdermal Scopolamine Sales by Application (2023-2028) & (K Units)
Table 66. Europe Transdermal Scopolamine Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Transdermal Scopolamine Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Transdermal Scopolamine Sales by Country (2017-2022) & (K Units)
Table 69. Europe Transdermal Scopolamine Sales by Country (2023-2028) & (K Units)
Table 70. Europe Transdermal Scopolamine Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Transdermal Scopolamine Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Transdermal Scopolamine Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Transdermal Scopolamine Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Transdermal Scopolamine Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Transdermal Scopolamine Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Transdermal Scopolamine Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Transdermal Scopolamine Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Transdermal Scopolamine Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Transdermal Scopolamine Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Transdermal Scopolamine Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Transdermal Scopolamine Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Transdermal Scopolamine Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Transdermal Scopolamine Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Transdermal Scopolamine Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Transdermal Scopolamine Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Transdermal Scopolamine Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Transdermal Scopolamine Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Transdermal Scopolamine Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Transdermal Scopolamine Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Transdermal Scopolamine Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Transdermal Scopolamine Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Transdermal Scopolamine Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Transdermal Scopolamine Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Transdermal Scopolamine Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Transdermal Scopolamine Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Transdermal Scopolamine Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Transdermal Scopolamine Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Transdermal Scopolamine Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Transdermal Scopolamine Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Transdermal Scopolamine Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Transdermal Scopolamine Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Transdermal Scopolamine Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Transdermal Scopolamine Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Transdermal Scopolamine Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Transdermal Scopolamine Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Transdermal Scopolamine Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Transdermal Scopolamine Revenue by Country (2023-2028) & (US$ Million)
Table 108. Baxter International Corporation Information
Table 109. Baxter International Description and Major Businesses
Table 110. Baxter International Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 111. Baxter International Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Baxter International Recent Developments
Table 113. GlaxoSmithKline Corporation Information
Table 114. GlaxoSmithKline Description and Major Businesses
Table 115. GlaxoSmithKline Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 116. GlaxoSmithKline Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. GlaxoSmithKline Recent Developments
Table 118. Novartis AG Corporation Information
Table 119. Novartis AG Description and Major Businesses
Table 120. Novartis AG Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 121. Novartis AG Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Novartis AG Recent Developments
Table 123. Perrigo Company Corporation Information
Table 124. Perrigo Company Description and Major Businesses
Table 125. Perrigo Company Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 126. Perrigo Company Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Perrigo Company Recent Developments
Table 128. Caleb Pharmaceuticals Corporation Information
Table 129. Caleb Pharmaceuticals Description and Major Businesses
Table 130. Caleb Pharmaceuticals Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 131. Caleb Pharmaceuticals Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Caleb Pharmaceuticals Recent Developments
Table 133. Myungmoon Pharma Corporation Information
Table 134. Myungmoon Pharma Description and Major Businesses
Table 135. Myungmoon Pharma Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 136. Myungmoon Pharma Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Myungmoon Pharma Recent Developments
Table 138. Pfizer Corporation Information
Table 139. Pfizer Description and Major Businesses
Table 140. Pfizer Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 141. Pfizer Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Pfizer Recent Developments
Table 143. Nichi-Iko Corporation Information
Table 144. Nichi-Iko Description and Major Businesses
Table 145. Nichi-Iko Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 146. Nichi-Iko Transdermal Scopolamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Nichi-Iko Recent Developments
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. Transdermal Scopolamine Distributors List
Table 151. Transdermal Scopolamine Customers List
Table 152. Transdermal Scopolamine Market Trends
Table 153. Transdermal Scopolamine Market Drivers
Table 154. Transdermal Scopolamine Market Challenges
Table 155. Transdermal Scopolamine Market Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Scopolamine Product Picture
Figure 3. Global Transdermal Scopolamine Market Share by Type in 2021 & 2028
Figure 3. Tablet Type Product Picture
Figure 4. Syrups Type Product Picture
Figure 5. Injections Type Product Picture
Figure 6. Patch Type Product Picture
Figure 7. Gel Type Product Picture
Figure 8. Global Transdermal Scopolamine Market Share by Application in 2021 & 2028
Figure 9. Narcotic Analgesia
Figure 10. Cough
Figure 11. Asthma
Figure 12. Motion Sickness
Figure 13. Parkinson's Disease
Figure 14. Others
Figure 15. Transdermal Scopolamine Report Years Considered
Figure 16. Global Transdermal Scopolamine Sales 2017-2028 (K Units)
Figure 17. Global Transdermal Scopolamine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Transdermal Scopolamine Revenue 2017-2028 (US$ Million)
Figure 19. Global Transdermal Scopolamine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Transdermal Scopolamine Sales Market Share by Region (2017-2022)
Figure 21. Global Transdermal Scopolamine Sales Market Share by Region (2023-2028)
Figure 22. North America Transdermal Scopolamine Sales YoY (2017-2028) & (K Units)
Figure 23. North America Transdermal Scopolamine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Transdermal Scopolamine Sales YoY (2017-2028) & (K Units)
Figure 25. Europe Transdermal Scopolamine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Transdermal Scopolamine Sales YoY (2017-2028) & (K Units)
Figure 27. Asia-Pacific Transdermal Scopolamine Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Transdermal Scopolamine Sales YoY (2017-2028) & (K Units)
Figure 29. Latin America Transdermal Scopolamine Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Transdermal Scopolamine Sales YoY (2017-2028) & (K Units)
Figure 31. Middle East & Africa Transdermal Scopolamine Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Transdermal Scopolamine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Transdermal Scopolamine in the World: Market Share by Transdermal Scopolamine Revenue in 2021
Figure 34. Global Transdermal Scopolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Transdermal Scopolamine Sales Market Share by Type (2017-2028)
Figure 36. Global Transdermal Scopolamine Revenue Market Share by Type (2017-2028)
Figure 37. Global Transdermal Scopolamine Sales Market Share by Application (2017-2028)
Figure 38. Global Transdermal Scopolamine Revenue Market Share by Application (2017-2028)
Figure 39. North America Transdermal Scopolamine Sales Market Share by Type (2017-2028)
Figure 40. North America Transdermal Scopolamine Revenue Market Share by Type (2017-2028)
Figure 41. North America Transdermal Scopolamine Sales Market Share by Application (2017-2028)
Figure 42. North America Transdermal Scopolamine Revenue Market Share by Application (2017-2028)
Figure 43. North America Transdermal Scopolamine Sales Share by Country (2017-2028)
Figure 44. North America Transdermal Scopolamine Revenue Share by Country (2017-2028)
Figure 45. U.S. Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Transdermal Scopolamine Sales Market Share by Type (2017-2028)
Figure 48. Europe Transdermal Scopolamine Revenue Market Share by Type (2017-2028)
Figure 49. Europe Transdermal Scopolamine Sales Market Share by Application (2017-2028)
Figure 50. Europe Transdermal Scopolamine Revenue Market Share by Application (2017-2028)
Figure 51. Europe Transdermal Scopolamine Sales Share by Country (2017-2028)
Figure 52. Europe Transdermal Scopolamine Revenue Share by Country (2017-2028)
Figure 53. Germany Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 54. France Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Transdermal Scopolamine Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Transdermal Scopolamine Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Transdermal Scopolamine Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Transdermal Scopolamine Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Transdermal Scopolamine Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Transdermal Scopolamine Revenue Share by Region (2017-2028)
Figure 64. China Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 67. India Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 69. China Taiwan Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Transdermal Scopolamine Sales Market Share by Type (2017-2028)
Figure 74. Latin America Transdermal Scopolamine Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Transdermal Scopolamine Sales Market Share by Application (2017-2028)
Figure 76. Latin America Transdermal Scopolamine Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Transdermal Scopolamine Sales Share by Country (2017-2028)
Figure 78. Latin America Transdermal Scopolamine Revenue Share by Country (2017-2028)
Figure 79. Mexico Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Transdermal Scopolamine Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Transdermal Scopolamine Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Transdermal Scopolamine Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Transdermal Scopolamine Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Transdermal Scopolamine Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Transdermal Scopolamine Revenue Share by Country (2017-2028)
Figure 88. Turkey Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 90. UAE Transdermal Scopolamine Revenue (2017-2028) & (US$ Million)
Figure 91. Transdermal Scopolamine Value Chain
Figure 92. Transdermal Scopolamine Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
Industry Market Size
